ホーム > 柴 綾/ Shiba, Aya
柴 綾
ALUMNI
2025年7月現在、筑波大学が主たる所属機関ではありません
Shiba, Aya
筑波大学 , 医学医療系 , 准教授 University of Tsukuba , Institute of Medicine , Associate Professor
-
TRiSTAR第4期フェロー(2024年)柴 綾
2024-09-01
柴 綾
オープンアクセス版の論文は「つくばリポジトリ」で読むことができます。
-
1.
Novel therapeutic strategies targeting bypass pathways and mitochondrial dysfunction to combat resistance to RET inhibitors in NSCLC
Aya Shiba-Ishii; Takayuki Isagawa; Toshihiro Shiozawa; Naoko Mato (+8 著者) Daisuke Matsubara
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 167249 (2024) Semantic Scholar
-
2.
Expression patterns of HNF4α, TTF‐1, and SMARCA4 in lung adenocarcinomas: impacts on clinicopathological and genetic features
Hitomi Kawai; Tamaki Miura; Natsumi Kawamatsu; Tomoki Nakagawa (+14 著者) Toshiro Niki
Virchows Archiv (2024)
-
3.
Histologic transformation of non-small-cell lung cancer in response to tyrosine kinase inhibitors: Current knowledge of genetic changes and molecular mechanisms.
Aya Shiba-Ishii, Noriko Takemura, Hitomi Kawai, Daisuke Matsubara
Cancer Science (2024)
-
4.
Spectrum of diverse compound resistance mutations and roadmap for targeting them in ALK-positive lung cancer
Shiba, Aya; Johnson, Ted W.; Dagogo-Jack, Ibiayi; Mino-Kenudson, Mari (+3 著者) Hata, Aaron N.
CANCER SCIENCE 115: 1104 (2024)
-
5.
Investigation for on-target resistance mechanism to ALK inihbitors and development of novel therapiutic strategy to target early-stage lnug adenocarcinoma
Shiba, Aya; Yoda, Satoshi; Hata, Aaron N.; Hirokawa, Takatsugu (+1 著者) Matsubara, Daisuke
CANCER SCIENCE 115: 1261 (2024)
-
6.
Mutational landscape of primary breast angiosarcoma with repeated resection and recurrence over a 15-year period: A case report
Teruyama, Fumiya; Kuno, Akihiro; Murata, Yoshihiko; Nakagawa, Tomoki (+2 著者) Noguchi, Masayuki
PATHOLOGY INTERNATIONAL 72: 457 (2022) Semantic Scholar
-
7.
Analysis of lorlatinib analogs reveals a roadmap for targeting diverse compound resistance mutations in ALK-positive lung cancer
Shiba-Ishii, Aya; Johnson, Ted; Dagogo-Jack, Ibiayi; Mino-Kenudson, Mari (+19 著者) Hata, Aaron N
Nature cancer 3: 710 (2022) Semantic Scholar
-
8.
Significance of stratifin in early progression of lung adenocarcinoma and its potential therapeutic relevance
Shiba-Ishii, Aya
PATHOLOGY INTERNATIONAL 71: 655 (2021) Semantic Scholar
-
9.
Ovarian carcinoma immunoreactive antigen domain 2 controls mitochondrial apoptosis in lung adenocarcinoma
Hong, Jeongmin; Shiba-Ishii, Aya; Kim, Yunjung; Noguchi, MasayukiSakamoto, Noriaki
Cancer science Epub: (2021) Semantic Scholar
-
10.
Gene expression profiles of the original tumors influence the generation of PDX models of lung squamous cell carcinoma
Kim, Yunjung; Shiba-Ishii, Aya; Nakagawa, Tomoki; Takeuchi, Tomoyo (+3 著者) Sakamoto, Noriaki
LABORATORY INVESTIGATION Epub: (2021) Semantic Scholar
-
11.
Gene expression profiles of the original tumors influence the generation of PDX models of lung squamous cell carcinoma
Kim, Yunjung; Shiba-Ishii, Aya; Nakagawa, Tomoki; Takeuchi, Tomoyo (+3 著者) Sakamoto, Noriaki
LABORATORY INVESTIGATION Epub: (2021) Semantic Scholar
-
12.
Gene expression profiles of the original tumors influence the generation of PDX models of lung squamous cell carcinoma
Kim, Yunjung; Shiba-Ishii, Aya; Nakagawa, Tomoki; Takeuchi, Tomoyo (+3 著者) Sakamoto, Noriaki
LABORATORY INVESTIGATION Epub: (2021) Semantic Scholar
-
13.
Carcinogen-induced tumors in SFN-transgenic mice harbor a characteristic mutation spectrum of human lung adenocarcinoma
Kim, Yunjung; Shiba-Ishii, Aya; Ramirez, Karina; Muratani, Masafumi (+2 著者) Noguchi, Masayuki
Cancer science 110: 2431 (2019) Semantic Scholar
-
14.
DNA hypomethylation-related overexpression of SFN, GORASP2 and ZYG11A is a novel prognostic biomarker for early stage lung adenocarcinoma
Husni; Ryan Edber; Shiba-Ishii, Aya; Nakagawa, Tomoki (+6 著者) Noguchi, Masayuki
Oncotarget 10: 1625 (2019) Semantic Scholar
-
15.
Stratifin inhibits SCFFBW7 formation and blocks ubiquitination of oncoproteins during the course of lung adenocarcinogenesis
Shiba-Ishii, Aya; Hong, Jeongmin; Hirokawa, Takatsugu; Kim, Yunjung (+5 著者) Noguchi, Masayuki
Clinical cancer research : an official journal of the American Association for Cancer Research 25: 2809 (2019) Semantic Scholar
-
16.
Heterotopic Expression of Ceruloplasmin in Lung Adenocarcinoma and its Possible Clinical Use as a Tumor Biomarker
Matsuoka, R; Shiba, A; Sakashita, S; Minami, YNoguchi, M
JOURNAL OF THORACIC ONCOLOGY 13: S561 (2018) Semantic Scholar
-
17.
The Novel SFN Inhibitors Aprepitant and Ticagrelor Exert Anti-Tumor Effects Through Blocking of Oncoprotein Ubiquitination
Shiba, A; Hong, J; Hirokawa, T; Kim, YNoguchil, M
JOURNAL OF THORACIC ONCOLOGY 13: S519 (2018) Semantic Scholar
-
18.
High expression of ovarian cancer immunoreactive antigen domain containing 2 (OCIAD2) is associated with poor prognosis in lung adenocarcinoma
Sakashita, Mai; Sakashita, Shingo; Murata, Yoshihiko; Shiba-Ishii, Aya (+4 著者) Noguchi, Masayuki
Pathology international 68: 596 (2018) Semantic Scholar
-
19.
Stratifin regulates stabilization of receptor tyrosine kinases via interaction with ubiquitin-specific protease 8 in lung adenocarcinoma
Kim, Yunjung; Shiba-Ishii, Aya; Nakagawa, Tomoki; Iemura, Shun-Ichiro (+7 著者) Noguchi, Masayuki
Oncogene 37: 5387 (2018) Semantic Scholar
-
20.
Heterotopic production of ceruloplasmin by lung adenocarcinoma is significantly correlated with prognosis
Ryota Matsuoka; Aya Shiba-Ishii; Noriyuki Nakano; Akira Togayachi (+3 著者) Masayuki Noguchi
Lung Cancer 118: 97 (2018) Semantic Scholar
-
1.
医学のあゆみ Vol.277 No.12
野口, 雅之; 柴 綾
医歯薬出版 2021年6月
-
2.
病理と臨床
柴,綾; 里見 介史; 野口 雅之
(担当:分担執筆, 範囲:マイクロダイセクション法)
2011年4月
-
21.
Analysis of lorlatinib analogs reveals roadmap for targeting compound resistance mutations in ALK-positive lung cancer
Shiba, Aya
第81回日本癌学会学術総会 招待有り
-
1. 特願2017-134106: 抗がん剤
広川, 貴次; 野口, 雅之; 柴, 綾 -
2. 特願2017-134106: 抗がん剤
広川, 貴次; 野口, 雅之; 柴, 綾
521 total views